The mean ranks for each of the genes between AML and CML indicated upregulation of cyclin D3 in CML in comparison with AML in the CD34+ve fraction, whereas it was upregulated in the total BM fraction, and there was no significant difference (p≤0.39). The gene discussed is CCND3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.